Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection

[1]  A. Stenzinger,et al.  SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas , 2021, Nature Metabolism.

[2]  Introduction: Standards of Medical Care in Diabetes-2021. , 2020, Diabetes care.

[3]  M. Atkinson,et al.  Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19 , 2020, Cell Metabolism.

[4]  Alaina P. Vidmar,et al.  New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19 , 2020, Journal of pediatric endocrinology & metabolism : JPEM.

[5]  Eric A. Meyerowitz,et al.  Efficacy of Tocilizumab in Patients Hospitalized with Covid-19 , 2020, The New England journal of medicine.

[6]  R. Gainetdinov,et al.  Beta-cells from patients with COVID-19 and from isolated human islets exhibit ACE2, DPP4, and TMPRSS2 expression, viral infiltration and necroptotic cell death , 2020 .

[7]  Zhènglì Shí,et al.  Characteristics of SARS-CoV-2 and COVID-19 , 2020, Nature Reviews Microbiology.

[8]  J. Bonventre,et al.  Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study , 2020, Diabetes Care.

[9]  E. Bonifacio,et al.  Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report , 2020, Nature Metabolism.

[10]  S. Del Prato,et al.  COVID-19 in people with diabetes: understanding the reasons for worse outcomes , 2020, The Lancet Diabetes & Endocrinology.

[11]  Anand Srivastava,et al.  Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. , 2020, JAMA internal medicine.

[12]  M. Boulton,et al.  SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes , 2020, Diabetes.

[13]  D. Montesi,et al.  Stress Hyperglycemia and Mortality in Subjects With Diabetes and Sepsis , 2020, Critical care explorations.

[14]  Duc-Huy T. Nguyen,et al.  A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids , 2020, Cell Stem Cell.

[15]  L. Montaner,et al.  Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts , 2020, Journal of leukocyte biology.

[16]  P. Fiorina,et al.  Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19 , 2020, Acta Diabetologica.

[17]  G. Paolisso,et al.  Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? , 2020, Diabetes Care.

[18]  S. Cole,et al.  The COVID-19 Pandemic during the Time of the Diabetes Pandemic: Likely Fraternal Twins? , 2020, Pathogens.

[19]  M. Tay,et al.  The trinity of COVID-19: immunity, inflammation and intervention , 2020, Nature Reviews Immunology.

[20]  Geltrude Mingrone,et al.  Practical recommendations for the management of diabetes in patients with COVID-19 , 2020, The Lancet Diabetes & Endocrinology.

[21]  Furong Liu,et al.  ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection , 2020, Clinical Gastroenterology and Hepatology.

[22]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[23]  N. Vaninov.  In the eye of the COVID-19 cytokine storm , 2020, Nature Reviews Immunology.

[24]  A. Avogaro,et al.  Prevalence and impact of diabetes among people infected with SARS-CoV-2 , 2020, Journal of Endocrinological Investigation.

[25]  Qiurong Ruan,et al.  Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.

[26]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[27]  Sheng-Qun Deng,et al.  Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China , 2020, Journal of clinical medicine.

[28]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[29]  Jennifer K. Sun,et al.  A Signature of Circulating Inflammatory Proteins and Development of End Stage Renal Disease in Diabetes , 2019, Nature Medicine.

[30]  B. Corkey,et al.  β-Cell Failure or β-Cell Abuse? , 2018, Front. Endocrinol..

[31]  G. Hotamışlıgil.  Inflammation, metaflammation and immunometabolic disorders , 2017, Nature.

[32]  Sofia Dahlqvist,et al.  Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial , 2017, JAMA.

[33]  R. Nagai,et al.  Islet inflammation in type 2 diabetes and physiology , 2017, The Journal of clinical investigation.

[34]  R. Bergman,et al.  Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series , 2016, Diabetes Care.

[35]  L. Marzban.  New Insights Into the Mechanisms of Islet Inflammation in Type 2 Diabetes , 2015, Diabetes.

[36]  N. Morgan,et al.  Detection of a Low-Grade Enteroviral Infection in the Islets of Langerhans of Living Patients Newly Diagnosed With Type 1 Diabetes , 2014, Diabetes.

[37]  C. Jenkinson,et al.  The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus , 2014, Acta Diabetologica.

[38]  J. Ilonen,et al.  Coxsackievirus B1 Is Associated With Induction of β-Cell Autoimmunity That Portends Type 1 Diabetes , 2014, Diabetes.

[39]  D. Hallinger,et al.  Association of proinflammatory cytokines and islet resident leucocytes with islet dysfunction in type 2 diabetes , 2014, Diabetologia.

[40]  A. Falini,et al.  Islet Transplantation Stabilizes Hemostatic Abnormalities and Cerebral Metabolism in Individuals With Type 1 Diabetes , 2013, Diabetes Care.

[41]  R. de Cássia Gonçalves Alfenas,et al.  The role of hyperglycemia in the induction of oxidative stress and inflammatory process. , 2012, Nutricion hospitalaria.

[42]  P. Fiorina,et al.  Impact of Islet Transplantation on Diabetes Complications and Quality of Life , 2011, Current diabetes reports.

[43]  R. DeFronzo,et al.  Effects of insulin and oral anti‐diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects , 2011, Diabetes/metabolism research and reviews.

[44]  P. Halban,et al.  Cytokine production by islets in health and diabetes: cellular origin, regulation and function , 2010, Trends in Endocrinology & Metabolism.

[45]  C. Jenkinson,et al.  Proteomics Reveals Novel Oxidative and Glycolytic Mechanisms in Type 1 Diabetic Patients' Skin Which Are Normalized by Kidney-Pancreas Transplantation , 2010, PloS one.

[46]  R. DeFronzo,et al.  Abstract: 1016 IMPAIRED REGULATION OF TACE/TIMP3 PROTEOLYTIC SYSTEM IN SKELETAL MUSCLE OF OBESE TYPE 2 DIABETIC SUBJECTS. A NEW MECHANISM OF INSULIN RESISTANCE IN HUMANS , 2009 .

[47]  Jin-Kui Yang,et al.  Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes , 2009, Acta Diabetologica.

[48]  J. Manson,et al.  Insulin Sensitivity and Insulin Secretion Determined by Homeostasis Model Assessment and Risk of Diabetes in a Multiethnic Cohort of Women , 2007, Diabetes Care.

[49]  K. Kalia,et al.  Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy. , 2007, Cellular and molecular biology.

[50]  J. Chan,et al.  Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[51]  S. Bonner-Weir,et al.  Five stages of evolving beta-cell dysfunction during progression to diabetes. , 2004, Diabetes.

[52]  Qingling Zhang,et al.  Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways , 2004, The Journal of pathology.

[53]  R. Lehmann,et al.  Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation. , 2001, Diabetes care.

[54]  R. Kulkarni,et al.  A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes. , 2000, Diabetes.

[55]  F. Fazio,et al.  Patient Survival and Cardiovascular Events after Kidney–Pancreas Transplantation: Comparison with Kidney Transplantation Alone in Uremic IDDM Patients , 2000, Cell transplantation.

[56]  H. Vestergaard,et al.  Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. , 1999, Diabetes care.

[57]  P. Fiorina,et al.  Left ventricular function in insulin-dependent and in non-insulin-dependent diabetic patients: radionuclide assessment. , 1997, Cardiology.

[58]  R. DeFronzo.  Pathogenesis of Type 2 (non-insulin dependent) diabetes mellitus: a balanced overview , 1992, Diabetologia.

[59]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[60]  P. Higgins,et al.  Exenatide regulates pancreatic islet integrity and insulin sensitivity in baboons , 2019 .

[61]  Mary Linnea Nelson,et al.  Health Care Worker Incidents Reported in a Rural Health Care Facility , 1996, AAOHN journal : official journal of the American Association of Occupational Health Nurses.

[62]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[63]  No Authors.  Standards of Medical Care in Diabetes — 2021 , 2022, KIDNEYS.